Bio Developments

© GettyImages/Image Source

Lilly and Merus set to collaborate on cancer therapies

By Jane Byrne

Loxo Oncology at Lilly, an R&D division of Eli Lilly and Co, and Merus, a Dutch clinical-stage oncology company, today announced a partnership to research and develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies.


Sanofi to acquire Kymab for up to $1.45bn

By Rachel Arthur

Sanofi will acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies. The acquisition will give it global rights to KY1005, which has the potential to treat a range of immune-mediated diseases and inflammatory...

Follow us


View more